Oral naltrexone as a treatment for relapse prevention in formerly opioid-dependent drug users: a systematic review and economic evaluation

Oral naltrexone as a treatment for relapse prevention in formerly opioid-dependent drug users: a systematic review and economic evaluation

Bibliographic Details
Main Authors:	Y Adi, A Juarez-Garcia, D Wang, S Jowett, E Frew, E Day, S Bayliss, T Roberts, A Burls
Format:	Article
Language:	English
Published:	NIHR Journals Library 2007-02-01
Series:	Health Technology Assessment
Online Access:	https://doi.org/10.3310/hta11060

Similar Items

Thyroid Function of Former Opioid Addicts on Naltrexone Treatment
by: Ioannis Ilias, et al.
Published: (2001-01-01)

Impact of naltrexone preventation of relapse opiate dependence
by: Nazer Mohammad, et al.
Published: (2006-02-01)

Extended-release naltrexone versus standard oral naltrexone versus placebo for opioid use disorder: the NEAT three-arm RCT
by: John Strang, et al.
Published: (2019-01-01)

Effectiveness of Naltrexone Combined with Psychotherapy in the Relapse Prevention of Alcohol Dependence
by: Chao-Hsiang Hsieh, et al.
Published: (2006)

Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation
by: M Connock, et al.
Published: (2007-03-01)

Effectiveness of Naltrexone in the Prevention of Delayed Respiratory Arrest in Opioid-Naive Methadone-Intoxicated Patients
by: Abbas Aghabiklooei, et al.
Published: (2013-01-01)

Buprenorphine therapy in the setting of induced opioid withdrawal from oral naltrexone: a case report
by: Laura M. Szczesniak, et al.
Published: (2020-10-01)

Effectiveness of buprenorphine in detoxification and naltrexone in relapse prevention of tramadol-dependent patients: A case series
by: Vijaya Chandra Reddy Avula
Published: (2021-01-01)

Comment on “Effectiveness of Naltrexone in the Prevention of Delayed Respiratory Arrest in Opioid-Naive Methadone-Intoxicated Patients”
by: Abbas Aghabiklooei, et al.
Published: (2015-01-01)

Comment on “Effectiveness of Naltrexone in the Prevention of Delayed Respiratory Arrest in Opioid-Naive Methadone-Intoxicated Patients”
by: Benjamin D. Kessler, et al.
Published: (2014-01-01)

The Effects of Low Dose Naltrexone on Opioid Induced Hyperalgesia and Fibromyalgia
by: Daniel Jackson, et al.
Published: (2021-02-01)

Pharmacological enhancement of naltrexone treatment for opioid dependence: a review
by: Peindl K, et al.
Published: (2011-06-01)

Naltrexone extended-release injection: an option for the management of opioid abuse
by: Taylor Jr R, et al.
Published: (2011-12-01)

Long-Acting Injectable Naltrexone for the Management of Patients with Opioid Dependence
by: Kimberly L. Kjome, et al.
Published: (2011-02-01)

Long-Acting Injectable naltrexone for the Management of patients with Opioid Dependence
by: Kimberly L. Kjome, et al.
Published: (2011-01-01)

Enhancement of Cisplatin Nephrotoxicity by Morphine and Its Attenuation by the Opioid Antagonist Naltrexone
by: Atefeh Aminian, et al.
Published: (2016-07-01)

Effects of naltrexone on pain sensitivity and mood in fibromyalgia: no evidence for endogenous opioid pathophysiology.
by: Jarred W Younger, et al.
Published: (2009-01-01)

Naltrexone maintenance therapy with pellet implantation as an aid for relapse prevention of heroin dependent individuals : a South African perspective
by: Van der Walt, Hugo Denton
Published: (2017)

Intranasal Low-Dose Naltrexone Against Opioid Side Effects: A Preclinical Study
by: Laura Micheli, et al.
Published: (2020-09-01)

Ethanol/naltrexone interactions at the mu-opioid receptor. CLSM/FCS study in live cells.
by: Vladana Vukojević, et al.
Published: (2008-01-01)

The opioid antagonist naltrexone decreases seizure‐like activity in genetic and chemically induced epilepsy models
by: Morgan L. Sturgeon, et al.
Published: (2021-09-01)

Comparison of the risk of drop-out from opioid maintenance treatment in patients using naltrexone implants vs. oral buprenorphine-naloxone (tur)
by: Umut Kırlı, et al.
Published: (2021-09-01)

DESIGN, SYNTHESES, AND BIOLOGICAL EVALUATION OF 14-N-SUBSTITUTED NALTREXONE DERIVATIVES AS OPIOID RECEPTOR LIGANDS
by: Elbegdorj, Orgil
Published: (2013)

Assessing the Subjective and Physiological Effects of Intranasally Administered Crushed Extended-Release Morphine Formulations with and without a Sequestered Naltrexone Core in Recreational Opioid Users
by: Beatrice Setnik, et al.
Published: (2013-01-01)

Evaluation of Different Doses of Fentanyl in Controlling Agitation in Acute Opioid Withdrawal Syndrome Induced by Naltrexone Misuse
by: Farzad Gheshlaghi, et al.
Published: (2012-03-01)

Low-dose and high-dose naltrexone in opioid dependence syndrome: a three months outcome study
by: Ajeet Sidana, et al.
Published: (2019-06-01)

Open Label Trial of Naltrexone Implants: Measuring Blood Serum Levels of Naltrexone
by: Ross M. Colquhoun
Published: (2013-05-01)

Open Label Trial of Naltrexone Implants: Measuring Blood Serum Levels of Naltrexone
by: Ross M. Colquhoun
Published: (2013-01-01)

Epidemiologic and Molecular Pathophysiology of Chronic Opioid Dependence and the Place of Naltrexone Extended-Release Formulations in its Clinical Management
by: Albert Stuart Reece
Published: (2012-01-01)

Epidemiologic and Molecular Pathophysiology of Chronic Opioid Dependence and the Place of Naltrexone Extended-Release Formulations in its Clinical Management
by: Albert Stuart Reece
Published: (2012-09-01)

Effectiveness of Mindfulness-Based Relapse Prevention in opioid Dependence Treatment &Mental Health
Published: (2008-11-01)

Naltrexone‐induced drug eruption
by: Johannes Heck, et al.
Published: (2020-10-01)

Inhibition of 7, 12-Dimethylbenz(a)anthracene Induced Rat Mammary Tumors by Naltrexone and Its Effect on Opioid Peptides /
by: Koo, Kwok Leung
Published: (1996)

The Need for Psychosocial Interventions to Facilitate the Transition to Extended-Release Naltrexone (XR-NTX) Treatment for Opioid Dependence: A Concise Review of the Literature
by: Susan E. Ramsey, et al.
Published: (2016-08-01)

The Need for Psychosocial Interventions to Facilitate the Transition to Extended-Release Naltrexone (XR-NTX) Treatment for Opioid Dependence: A Concise Review of the Literature
by: Susan E. Ramsey, et al.
Published: (2016-01-01)

Microbiological Estimation of Nasal Spray Containing Naltrexone Hydrochloride
by: Yu. M. Domnina, et al.
Published: (2020-11-01)

Can we prevent drug related deaths by training opioid users to recognise and manage overdoses?
by: Manning Victoria, et al.
Published: (2009-09-01)

RATIONALE FOR THE SELECTION OF AUXILIARY COMPONENTS FOR THE NALTREXONE HYDROCHLORIDE NASAL SPRAY
by: Y. M. Domnina, et al.
Published: (2019-01-01)

Quantitative Determination of Benzalconium Chloride in the Naltrexone Hydrochloride Nasal Spray
by: Yu. M. Domnina, et al.
Published: (2020-11-01)

DEVELOPMENT OF A METHOD FOR THE PREPARATION OF THE NALTREXONE BASE ENCAPSULATED IN POLYMERIC MICROPARTICLES
by: S. A. Kedik, et al.
Published: (2019-01-01)